INSULIN LISPRO

INSULIN LISPRO was reported 138665 times

INSULIN LISPRO is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HYPOGLYCAEMIA UNAWARENESS 136 0.3799
1 NEUROLOGIC NEGLECT SYNDROME 181 0.3255
2 ANTI-INSULIN ANTIBODY POSITIVE 61 0.2919
3 HYPOGLYCAEMIC UNCONSCIOUSNESS 483 0.2437
4 INSULIN RESISTANCE 504 0.2420
5 INCREASED INSULIN REQUIREMENT 57 0.2405
6 BLOOD KETONE BODY 83 0.2392
7 CAROTID ARTERY THROMBOSIS 188 0.2214
8 INTERCEPTED DRUG DISPENSING ERROR 323 0.2171
9 INTERCEPTED PRODUCT SELECTION ERROR 273 0.2097
10 BLOOD GLUCOSE INCREASED 39129 0.2075
11 INCORRECT DRUG DOSAGE FORM ADMINISTERED 125 0.2049
12 HYPOGLYCAEMIC SEIZURE 182 0.2004
13 DIABETIC RETINOPATHY 654 0.1924
14 BLOOD GLUCOSE DECREASED 8914 0.1854
15 SHOCK HYPOGLYCAEMIC 87 0.1828
16 BLOOD GLUCOSE FLUCTUATION 1796 0.1637
17 BLOOD GLUCOSE ABNORMAL 2969 0.1606
18 ADJUSTMENT DISORDER 181 0.1392
19 ACCIDENTAL UNDERDOSE 1993 0.1383
20 NEUROPATHIC ARTHROPATHY 87 0.1345
21 WRONG DRUG ADMINISTERED 1189 0.1333
22 DIABETIC EYE DISEASE 59 0.1305
23 GLYCOSYLATED HAEMOGLOBIN INCREASED 3212 0.1271
24 WRONG PATIENT RECEIVED PRODUCT 347 0.1185
25 INCORRECT PRODUCT FORMULATION ADMINISTERED 101 0.1141
26 HYPOGLYCAEMIC COMA 316 0.1095
27 DIABETES MELLITUS INADEQUATE CONTROL 1926 0.1087
28 BLOOD KETONE BODY INCREASED 83 0.1063
29 DIABETIC RETINAL OEDEMA 50 0.0984
30 DIABETIC NEUROPATHY 463 0.0934
31 DRUG DISPENSING ERROR 1392 0.0910
32 DIABETIC COMPLICATION 231 0.0906
33 INCORRECT PRODUCT STORAGE 1182 0.0899
34 RETINOPATHY 330 0.0884
35 HYPOGLYCAEMIA 3900 0.0803
36 DIABETIC COMA 222 0.0792
37 MULTI-ORGAN DISORDER 150 0.0762
38 DIABETIC KETOACIDOSIS 1796 0.0747
39 DIABETIC ULCER 53 0.0743
40 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 78 0.0734
41 PERSONALITY DISORDER 188 0.0717
42 FOETAL DISORDER 56 0.0670
43 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 79 0.0659
44 NEPHROGENIC ANAEMIA 296 0.0638
45 HYPERPARATHYROIDISM SECONDARY 159 0.0634
46 POOR QUALITY DRUG ADMINISTERED 405 0.0625
47 LARGE FOR DATES BABY 55 0.0623
48 EYE HAEMORRHAGE 830 0.0621
49 GANGRENE 374 0.0620
50 KETOACIDOSIS 448 0.0598
51 URINE KETONE BODY PRESENT 90 0.0570
52 GLYCOSYLATED HAEMOGLOBIN DECREASED 91 0.0565
53 DIABETIC METABOLIC DECOMPENSATION 78 0.0562
54 KETOSIS 60 0.0553
55 WRONG PRODUCT ADMINISTERED 364 0.0538
56 DIABETIC FOOT 163 0.0532
57 VISUAL ACUITY REDUCED 1740 0.0523
58 HYPERGLYCAEMIA 1863 0.0511
59 ARTERIAL OCCLUSIVE DISEASE 370 0.0470
60 UNDERDOSE 3383 0.0463
61 INJECTION SITE SCAR 131 0.0459
62 VISUAL IMPAIRMENT 5630 0.0454
63 IMPAIRED GASTRIC EMPTYING 616 0.0451
64 INJURY ASSOCIATED WITH DEVICE 914 0.0448
65 GASTROINTESTINAL HYPOMOTILITY 99 0.0439
66 DIABETIC NEPHROPATHY 96 0.0436
67 CATARACT 2594 0.0435
68 HYPOGLYCAEMIA NEONATAL 69 0.0426
69 INFUSION SITE HAEMORRHAGE 140 0.0425
70 MACULAR DEGENERATION 501 0.0419
71 INCORRECT DOSE ADMINISTERED 9537 0.0417
72 RETINAL DISORDER 107 0.0411
73 PANCREATIC DISORDER 200 0.0406
74 WRONG PATIENT RECEIVED MEDICATION 108 0.0395
75 INFUSION SITE IRRITATION 49 0.0381
76 NEUROPATHY 64 0.0376
77 BLINDNESS UNILATERAL 518 0.0367
78 FRUSTRATION 130 0.0363
79 DIABETIC FOOT INFECTION 49 0.0346
80 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 186 0.0341
81 SENSORY LOSS 272 0.0338
82 FOOT AMPUTATION 49 0.0337
83 NASAL OBSTRUCTION 63 0.0336
84 END STAGE RENAL DISEASE 603 0.0330
85 BLINDNESS 1345 0.0330
86 PRODUCT STORAGE ISSUE 125 0.0330
87 HEMIPLEGIA 268 0.0322
88 HYPOACUSIS 1374 0.0319
89 RENAL TRANSPLANT 115 0.0318
90 PANCREATIC CYST 58 0.0303
91 HEARING IMPAIRED 182 0.0303
92 EARLY SATIETY 59 0.0303
93 PANCREATIC FAILURE 53 0.0300
94 DEVICE OPERATIONAL ISSUE 129 0.0300
95 RETINAL DETACHMENT 273 0.0297
96 SYSTEMIC INFECTION 49 0.0295
97 REBOUND ACID HYPERSECRETION 88 0.0291
98 TYPE 1 DIABETES MELLITUS 175 0.0290
99 THERAPEUTIC RESPONSE DELAYED 81 0.0289
100 INJECTION SITE INJURY 160 0.0288
101 BLOOD PRESSURE DIASTOLIC ABNORMAL 73 0.0287
102 PHARMACEUTICAL PRODUCT COMPLAINT 724 0.0279
103 TOE AMPUTATION 141 0.0277
104 LEG AMPUTATION 110 0.0267
105 GLAUCOMA 510 0.0265
106 EXPIRED PRODUCT ADMINISTERED 875 0.0263
107 MYOPIA 61 0.0256
108 INCORRECT PRODUCT ADMINISTRATION DURATION 549 0.0253
109 PANCREATIC CARCINOMA METASTATIC 69 0.0242
110 OVERWEIGHT 130 0.0242
111 RETINAL HAEMORRHAGE 170 0.0238
112 PANCREATITIS CHRONIC 56 0.0236
113 MOTOR DYSFUNCTION 239 0.0234
114 EXPOSURE DURING BREAST FEEDING 77 0.0232
115 PRE-ECLAMPSIA 108 0.0227
116 DRUG DOSE OMISSION 3752 0.0227
117 PERIPHERAL VASCULAR DISORDER 116 0.0225
118 EYE DISORDER 740 0.0225
119 THIRST 400 0.0224
120 INTENTIONAL DEVICE MISUSE 97 0.0220
121 THYROID DISORDER 337 0.0218
122 MALNUTRITION 242 0.0216
123 CYSTIC FIBROSIS 116 0.0209
124 POOR PERIPHERAL CIRCULATION 89 0.0209
125 CORONARY ARTERY OCCLUSION 286 0.0208
126 TRIGGER FINGER 85 0.0208
127 VITREOUS HAEMORRHAGE 56 0.0202
128 PRODUCT STORAGE ERROR 1769 0.0202
129 AFFECT LABILITY 194 0.0201
130 CORONARY ARTERY BYPASS 115 0.0200
131 SINUS CONGESTION 270 0.0200
132 ABSCESS LIMB 85 0.0199
133 VASCULAR GRAFT 56 0.0194
134 FINE MOTOR SKILL DYSFUNCTION 56 0.0193
135 LOCALISED INFECTION 462 0.0191
136 NECROTISING FASCIITIS 67 0.0190
137 THROAT CLEARING 71 0.0189
138 ARTHRITIS 1485 0.0189
139 SPINAL COLUMN STENOSIS 89 0.0188
140 INCORRECT DOSAGE ADMINISTERED 92 0.0188
141 HUNGER 260 0.0186
142 RENAL FAILURE CHRONIC 143 0.0186
143 DEMENTIA 515 0.0184
144 RENAL DISORDER 848 0.0182
145 EYE INJURY 55 0.0181
146 CHRONIC KIDNEY DISEASE 1373 0.0181
147 CATARACT OPERATION 107 0.0180
148 CARPAL TUNNEL SYNDROME 252 0.0180
149 HAEMORRHAGE 1862 0.0178
150 EXPIRED DRUG ADMINISTERED 88 0.0178
151 NEPHROPATHY 166 0.0178
152 EATING DISORDER 375 0.0176
153 NERVE INJURY 194 0.0174
154 INJECTION SITE INFECTION 57 0.0173
155 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 69 0.0169
156 SKIN HAEMORRHAGE 250 0.0169
157 LEFT VENTRICULAR HYPERTROPHY 72 0.0168
158 MUSCLE SPASTICITY 203 0.0165
159 HEMIPARESIS 279 0.0165
160 CAROTID ARTERY OCCLUSION 60 0.0164
161 VARICES OESOPHAGEAL 49 0.0162
162 COORDINATION ABNORMAL 226 0.0162
163 SINUS DISORDER 319 0.0161
164 DIFFICULTY IN WALKING 55 0.0160
165 NEUROPATHY PERIPHERAL 1510 0.0159
166 ANGINA PECTORIS 451 0.0157
167 NERVE COMPRESSION 145 0.0157
168 CARDIAC FAILURE CONGESTIVE 1258 0.0156
169 SCAR 268 0.0156
170 LIMB INJURY 425 0.0156
171 ANKLE FRACTURE 242 0.0156
172 FOREIGN BODY 62 0.0155
173 RESPIRATORY TRACT CONGESTION 245 0.0154
174 OSTEOMYELITIS 279 0.0154
175 MEDICATION ERROR 856 0.0154
176 VISUAL DISTURBANCE 88 0.0153
177 RENAL FAILURE 2021 0.0152
178 MATERNAL EXPOSURE DURING BREAST FEEDING 61 0.0150
179 EUGLYCAEMIC DIABETIC KETOACIDOSIS 62 0.0150
180 EYE OPERATION 69 0.0150
181 BACK DISORDER 242 0.0149
182 FOOT FRACTURE 282 0.0149
183 CEREBROVASCULAR ACCIDENT 2490 0.0147
184 INCOHERENT 95 0.0147
185 CARDIAC OPERATION 126 0.0146
186 BLOOD POTASSIUM INCREASED 235 0.0145
187 INCORRECT DRUG ADMINISTRATION DURATION 405 0.0144
188 ARTERIOSCLEROSIS 135 0.0143
189 OBSTRUCTIVE AIRWAYS DISORDER 159 0.0143
190 POLYDIPSIA 56 0.0142
191 SKIN ULCER 366 0.0141
192 INJECTION SITE HAEMORRHAGE 1126 0.0141
193 HYPOVOLAEMIA 82 0.0140
194 INJECTION SITE NODULE 153 0.0139
195 CARDIAC VALVE DISEASE 79 0.0138
196 MEMORY IMPAIRMENT 1893 0.0138
197 STENT PLACEMENT 111 0.0138
198 ROAD TRAFFIC ACCIDENT 574 0.0137
199 INFUSION SITE PAIN 176 0.0136
200 CYSTITIS 432 0.0136
201 ANGIOPATHY 76 0.0135
202 SOPOR 178 0.0134
203 LOWER LIMB FRACTURE 257 0.0134
204 SNEEZING 300 0.0134
205 UPPER LIMB FRACTURE 262 0.0131
206 HEPATIC CIRRHOSIS 246 0.0131
207 MATERNAL EXPOSURE DURING PREGNANCY 1166 0.0131
208 PRODUCT DOSE OMISSION 850 0.0130
209 INJECTION SITE EXTRAVASATION 160 0.0130
210 SLEEP APNOEA SYNDROME 247 0.0129
211 HYPERKERATOSIS 71 0.0129
212 CORONARY ARTERY DISEASE 388 0.0128
213 INJECTION SITE BRUISING 1018 0.0127
214 CARDIAC DISORDER 1192 0.0127
215 ACUTE RESPIRATORY FAILURE 245 0.0127
216 LYMPHOEDEMA 88 0.0127
217 HYPERKALAEMIA 446 0.0127
218 ACUTE KIDNEY INJURY 1936 0.0126
219 INTERVERTEBRAL DISC DISORDER 54 0.0126
220 PRODUCT DISPENSING ERROR 274 0.0126
221 RENAL TUBULAR NECROSIS 123 0.0125
222 LOSS OF CONSCIOUSNESS 1606 0.0125
223 ROTATOR CUFF SYNDROME 160 0.0124
224 INTERVERTEBRAL DISC PROTRUSION 271 0.0124
225 PRODUCT DISPENSING ISSUE 53 0.0124
226 APHASIA 373 0.0123
227 DIALYSIS 172 0.0121
228 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 630 0.0121
229 BLINDNESS TRANSIENT 89 0.0121
230 PERICARDIAL EFFUSION 278 0.0120
231 BACK INJURY 130 0.0119
232 TIBIA FRACTURE 56 0.0119
233 BLOOD CHOLESTEROL INCREASED 556 0.0119
234 UROSEPSIS 110 0.0119
235 DIABETES MELLITUS 908 0.0119
236 SPINAL STENOSIS 49 0.0119
237 DRUG PRESCRIBING ERROR 228 0.0119
238 CELLULITIS 597 0.0118
239 HYPERVOLAEMIA 58 0.0117
240 ACCIDENT 139 0.0116
241 CONCUSSION 90 0.0116
242 AMMONIA INCREASED 59 0.0116
243 COLD SWEAT 203 0.0115
244 ACIDOSIS 88 0.0115
245 LIMB DISCOMFORT 356 0.0115
246 CARDIAC PACEMAKER INSERTION 68 0.0114
247 GENERALISED OEDEMA 141 0.0114
248 MEDICAL DEVICE COMPLICATION 84 0.0113
249 FULL BLOOD COUNT ABNORMAL 120 0.0113
250 INJECTION SITE DISCOMFORT 119 0.0113
251 HYPERHIDROSIS 1454 0.0113
252 GOUT 202 0.0112
253 HYPERLIPIDAEMIA 134 0.0112
254 VISUAL FIELD DEFECT 81 0.0112
255 ARTERIOSCLEROSIS CORONARY ARTERY 74 0.0112
256 INTERVERTEBRAL DISC DEGENERATION 103 0.0111
257 NERVOUSNESS 579 0.0111
258 MACULAR OEDEMA 62 0.0111
259 INJECTION SITE MASS 408 0.0110
260 FEAR 296 0.0110
261 EYE DISCHARGE 114 0.0110
262 HAEMOGLOBIN INCREASED 50 0.0110
263 HEPATIC ENCEPHALOPATHY 102 0.0109
264 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2207 0.0109
265 WEIGHT DECREASED 3029 0.0108
266 STOMACH DISCOMFORT 56 0.0108
267 DYSARTHRIA 407 0.0108
268 PANIC REACTION 78 0.0108
269 PULMONARY OEDEMA 483 0.0108
270 RENAL INJURY 320 0.0108
271 HEAD INJURY 340 0.0107
272 PRESYNCOPE 261 0.0107
273 FALL 3555 0.0107
274 DEAFNESS UNILATERAL 58 0.0105
275 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 68 0.0105
276 FOOD POISONING 56 0.0104
277 BLOOD POTASSIUM DECREASED 314 0.0104
278 WOUND 291 0.0104
279 TRANSIENT ISCHAEMIC ATTACK 350 0.0104
280 PREMATURE BABY 312 0.0104
281 DISCOMFORT 630 0.0103
282 HAND FRACTURE 73 0.0103
283 CEREBRAL DISORDER 76 0.0103
284 WEIGHT INCREASED 2296 0.0102
285 ANEURYSM 51 0.0102
286 POLLAKIURIA 427 0.0102
287 VISION BLURRED 1405 0.0102
288 PROTEIN URINE PRESENT 51 0.0102
289 JOINT INJURY 218 0.0102
290 FLUID RETENTION 517 0.0102
291 FRUSTRATION TOLERANCE DECREASED 82 0.0101
292 MYOCARDIAL INFARCTION 1770 0.0101
293 BLOOD PRESSURE ABNORMAL 198 0.0099
294 DEHYDRATION 1323 0.0099
295 IMPAIRED HEALING 324 0.0099
296 HIP FRACTURE 316 0.0098
297 STAPHYLOCOCCAL INFECTION 324 0.0098
298 LOW BIRTH WEIGHT BABY 78 0.0098
299 BRAIN INJURY 98 0.0098
300 PREMATURE LABOUR 55 0.0097
301 ELECTROLYTE IMBALANCE 113 0.0097
302 MYOPATHY 84 0.0097
303 ATRIOVENTRICULAR BLOCK 75 0.0097
304 DECUBITUS ULCER 79 0.0097
305 TREMOR 1586 0.0095
306 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 162 0.0095
307 INJECTION SITE PAIN 2925 0.0095
308 BLOOD UREA INCREASED 159 0.0095
309 VITREOUS FLOATERS 93 0.0095
310 SLUGGISHNESS 96 0.0094
311 INJECTION SITE INDURATION 122 0.0094
312 WOUND INFECTION 103 0.0094
313 PANCREATITIS ACUTE 211 0.0094
314 DEAFNESS 244 0.0093
315 MALAISE 4069 0.0093
316 GLOMERULAR FILTRATION RATE DECREASED 114 0.0093
317 BODY HEIGHT DECREASED 99 0.0092
318 CARDIAC MURMUR 80 0.0092
319 PYELONEPHRITIS 80 0.0092
320 DRUG EXPOSURE DURING PREGNANCY 313 0.0092
321 COMA 438 0.0092
322 RIB FRACTURE 189 0.0092
323 HYPOPHAGIA 234 0.0091
324 DEVICE FAILURE 139 0.0091
325 FEELING ABNORMAL 2185 0.0091
326 PANCREATIC CARCINOMA 263 0.0091
327 POST PROCEDURAL INFECTION 74 0.0091
328 POLYURIA 74 0.0090
329 FLUID OVERLOAD 131 0.0090
330 CONFUSIONAL STATE 1453 0.0090
331 PANCREATITIS 475 0.0090
332 BLOOD PRESSURE INCREASED 1368 0.0089
333 BRAIN NEOPLASM 82 0.0089
334 GASTROENTERITIS VIRAL 161 0.0089
335 OBESITY 142 0.0089
336 RENAL IMPAIRMENT 748 0.0089
337 INCORRECT DOSE ADMINISTERED BY DEVICE 232 0.0088
338 SEASONAL ALLERGY 125 0.0088
339 MENISCUS INJURY 54 0.0088
340 SCIATICA 140 0.0088
341 FEEDING DISORDER 178 0.0088
342 COELIAC DISEASE 86 0.0088
343 HYPOXIA 308 0.0087
344 BRADYPHRENIA 57 0.0087
345 CEREBRAL INFARCTION 213 0.0087
346 JOINT EFFUSION 60 0.0087
347 SPINAL FRACTURE 174 0.0087
348 HYPERTENSION 1836 0.0087
349 POST-TRAUMATIC STRESS DISORDER 58 0.0086
350 OEDEMA PERIPHERAL 1051 0.0086
351 APPETITE DISORDER 57 0.0086
352 HEPATIC STEATOSIS 160 0.0086
353 SEPSIS 958 0.0086
354 POSTOPERATIVE WOUND INFECTION 58 0.0086
355 THINKING ABNORMAL 160 0.0086
356 HEPATOMEGALY 84 0.0085
357 MYASTHENIA GRAVIS 69 0.0085
358 CARDIOMEGALY 105 0.0085
359 INCREASED APPETITE 163 0.0085
360 FIBROMYALGIA 207 0.0085
361 WRIST FRACTURE 102 0.0085
362 WEIGHT FLUCTUATION 89 0.0085
363 MAJOR DEPRESSION 62 0.0085
364 RENAL FAILURE ACUTE 360 0.0085
365 IRON DEFICIENCY ANAEMIA 78 0.0084
366 GASTROOESOPHAGEAL REFLUX DISEASE 680 0.0084
367 INFUSION SITE ERYTHEMA 71 0.0084
368 KIDNEY INFECTION 165 0.0084
369 MOBILITY DECREASED 604 0.0084
370 CLOSTRIDIUM DIFFICILE COLITIS 89 0.0084
371 OSTEOARTHRITIS 354 0.0083
372 DYSPNOEA EXERTIONAL 313 0.0083
373 GAIT DISTURBANCE 1589 0.0083
374 MENTAL IMPAIRMENT 201 0.0083
375 ERUCTATION 160 0.0083
376 PULMONARY CONGESTION 109 0.0083
377 MULTIPLE INJURIES 52 0.0083
378 BLOOD MAGNESIUM DECREASED 71 0.0082
379 FLANK PAIN 77 0.0082
380 ELECTROCARDIOGRAM ABNORMAL 64 0.0081
381 ANGINA UNSTABLE 53 0.0081
382 ABSCESS 130 0.0081
383 ATRIAL FLUTTER 65 0.0081
384 ATRIAL FIBRILLATION 793 0.0081
385 HYPOKINESIA 118 0.0081
386 COLON CANCER 121 0.0081
387 LEUKAEMIA 76 0.0080
388 DRUG ADMINISTRATION ERROR 247 0.0080
389 DISORIENTATION 318 0.0080
390 CAESAREAN SECTION 93 0.0080
391 BLOOD DISORDER 64 0.0080
392 SECRETION DISCHARGE 100 0.0080
393 PELVIC FRACTURE 62 0.0080
394 BLOOD SODIUM DECREASED 150 0.0079
395 INFLUENZA 881 0.0079
396 DYSGRAPHIA 52 0.0079
397 RHINORRHOEA 508 0.0079
398 SPINAL OSTEOARTHRITIS 69 0.0078
399 INCONTINENCE 83 0.0078
400 SKIN LACERATION 85 0.0078
401 DYSSTASIA 227 0.0078
402 ACUTE MYOCARDIAL INFARCTION 229 0.0078
403 SINUSITIS 795 0.0077
404 ADRENAL INSUFFICIENCY 94 0.0077
405 PRODUCT DOSE OMISSION ISSUE 2277 0.0077
406 DERMATITIS BULLOUS 56 0.0077
407 RENAL PAIN 82 0.0077
408 SPEECH DISORDER 404 0.0077
409 SCRATCH 81 0.0077
410 HICCUPS 63 0.0077
411 ATELECTASIS 74 0.0077
412 ECONOMIC PROBLEM 116 0.0076
413 DECREASED APPETITE 1768 0.0076
414 URINARY TRACT INFECTION 1295 0.0076
415 RENAL CYST 60 0.0075
416 PARALYSIS 108 0.0075
417 COVID-19 PNEUMONIA 89 0.0075
418 CHOLELITHIASIS 247 0.0075
419 MUSCULAR WEAKNESS 854 0.0075
420 MUSCLE STRAIN 65 0.0075
421 DEVICE MECHANICAL ISSUE 103 0.0075
422 CONTUSION 723 0.0075
423 TENDERNESS 78 0.0075
424 MENTAL STATUS CHANGES 207 0.0074
425 BLOOD PRESSURE DIASTOLIC DECREASED 55 0.0074
426 PRURITUS GENERALISED 161 0.0074
427 MUSCULOSKELETAL DISCOMFORT 128 0.0074
428 BLOOD CREATININE INCREASED 485 0.0074
429 INTENTIONAL PRODUCT MISUSE 650 0.0074
430 TUBULOINTERSTITIAL NEPHRITIS 139 0.0074
431 ISCHAEMIC STROKE 132 0.0074
432 ASTHENIA 2767 0.0074
433 FUNGAL INFECTION 245 0.0073
434 EYE INFECTION 83 0.0073
435 NASOPHARYNGITIS 1354 0.0073
436 POST PROCEDURAL COMPLICATION 141 0.0073
437 EXOSTOSIS 67 0.0073
438 SKIN REACTION 103 0.0073
439 FEELING JITTERY 139 0.0073
440 ABASIA 180 0.0073
441 LIGAMENT SPRAIN 72 0.0073
442 VITAMIN D DEFICIENCY 71 0.0073
443 GRIP STRENGTH DECREASED 64 0.0073
444 BIPOLAR DISORDER 79 0.0073
445 SPINAL COMPRESSION FRACTURE 60 0.0072
446 EXPOSURE DURING PREGNANCY 451 0.0072
447 PULMONARY HYPERTENSION 151 0.0072
448 OEDEMA 392 0.0072
449 PNEUMONIA 2336 0.0072
450 UNRESPONSIVE TO STIMULI 186 0.0072
451 GAIT INABILITY 240 0.0072
452 VIRAL INFECTION 238 0.0071
453 BLADDER DISORDER 71 0.0071
454 AMNESIA 464 0.0071
455 GENERAL PHYSICAL HEALTH DETERIORATION 825 0.0071
456 GASTROENTERITIS 104 0.0071
457 SHOCK HAEMORRHAGIC 58 0.0071
458 PULMONARY MASS 106 0.0071
459 HAEMATOCRIT DECREASED 141 0.0071
460 HYPOTHYROIDISM 227 0.0071
461 NEOPLASM MALIGNANT 473 0.0071
462 MASS 99 0.0071
463 VOMITING 3321 0.0071
464 NODULE 92 0.0070
465 MUSCULOSKELETAL DISORDER 134 0.0070
466 HAIR DISORDER 58 0.0070
467 ASPIRATION 77 0.0070
468 DISABILITY 138 0.0070
469 ASCITES 205 0.0070
470 BLOOD CALCIUM INCREASED 61 0.0069
471 MUSCLE ATROPHY 88 0.0069
472 EMPHYSEMA 70 0.0069
473 BRONCHITIS 513 0.0069
474 PERIPHERAL SWELLING 1066 0.0069
475 PROCEDURAL COMPLICATION 53 0.0069
476 ANOREXIA 89 0.0069
477 BLOOD TRIGLYCERIDES INCREASED 122 0.0069
478 ILLNESS 711 0.0069
479 CARDIAC FAILURE 554 0.0069
480 ANAL INCONTINENCE 62 0.0069
481 HIATUS HERNIA 89 0.0069
482 HYPERSOMNIA 197 0.0069
483 PERIPHERAL COLDNESS 94 0.0068
484 CHEST PAIN 1266 0.0068
485 NEURALGIA 166 0.0068
486 BACTERAEMIA 81 0.0068
487 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 117 0.0068
488 MUSCLE DISORDER 55 0.0068
489 HAEMODIALYSIS 57 0.0068
490 AUTOIMMUNE DISORDER 66 0.0068
491 ARTHROPOD BITE 50 0.0067
492 APHONIA 94 0.0067
493 HYPERCHOLESTEROLAEMIA 65 0.0067
494 ORTHOSTATIC HYPOTENSION 117 0.0067
495 BLOOD PRESSURE SYSTOLIC INCREASED 131 0.0067
496 JOINT DISLOCATION 71 0.0067
497 BLOOD ALBUMIN DECREASED 53 0.0067
498 MYOCARDIAL ISCHAEMIA 76 0.0067
499 PRODUCT PRESCRIBING ERROR 159 0.0067
500 TRICUSPID VALVE INCOMPETENCE 53 0.0067
501 INTERNATIONAL NORMALISED RATIO INCREASED 190 0.0067
502 PSEUDOMONAS INFECTION 57 0.0066
503 RESPIRATORY RATE INCREASED 59 0.0066
504 ACUTE CORONARY SYNDROME 55 0.0066
505 HYPOAESTHESIA ORAL 100 0.0066
506 ANAEMIA 1265 0.0066
507 LUNG DISORDER 325 0.0066
508 CHOLECYSTITIS 79 0.0066
509 ALTERED STATE OF CONSCIOUSNESS 143 0.0066
510 LACERATION 62 0.0066
511 ESCHERICHIA INFECTION 54 0.0066
512 INJECTION SITE DISCOLOURATION 82 0.0066
513 CHEST DISCOMFORT 672 0.0066
514 SYNCOPE 656 0.0065
515 PHARYNGEAL SWELLING 64 0.0065
516 DYSPEPSIA 643 0.0065
517 PREMATURE DELIVERY 104 0.0065
518 ARTHROPATHY 363 0.0065
519 PALPITATIONS 763 0.0065
520 TYPE 2 DIABETES MELLITUS 219 0.0065
521 THROMBOSIS 521 0.0065
522 LIVER DISORDER 287 0.0065
523 ABDOMINAL DISTENSION 673 0.0064
524 DEPRESSED LEVEL OF CONSCIOUSNESS 255 0.0064
525 SPINAL DISORDER 61 0.0064
526 CARDIOVASCULAR DISORDER 163 0.0064
527 NEPHROLITHIASIS 293 0.0064
528 DIVERTICULITIS 177 0.0064
529 ABDOMINAL PAIN UPPER 1315 0.0064
530 BALANCE DISORDER 552 0.0064
531 GASTROINTESTINAL DISORDER 571 0.0064
532 MITRAL VALVE INCOMPETENCE 72 0.0064
533 NAUSEA 5034 0.0064
534 CARDIOMYOPATHY 94 0.0064
535 SEPTIC SHOCK 275 0.0063
536 DECREASED ACTIVITY 68 0.0063
537 INTERNAL HAEMORRHAGE 72 0.0063
538 DRUG INEFFECTIVE 8284 0.0063
539 SUBARACHNOID HAEMORRHAGE 64 0.0063
540 MELAENA 138 0.0063
541 BLOOD ALKALINE PHOSPHATASE INCREASED 155 0.0062
542 HAEMOPTYSIS 174 0.0062
543 BLOOD IRON DECREASED 74 0.0062
544 ENCEPHALOPATHY 153 0.0062
545 FOOT DEFORMITY 69 0.0062
546 FOETAL EXPOSURE DURING PREGNANCY 506 0.0062
547 PAIN IN EXTREMITY 1829 0.0062
548 FURUNCLE 49 0.0062
549 WRONG TECHNIQUE IN DRUG USAGE PROCESS 224 0.0062
550 DYSPHONIA 359 0.0061
551 DIZZINESS 3051 0.0061
552 HYPOKALAEMIA 282 0.0061
553 RETCHING 130 0.0061
554 BONE DISORDER 111 0.0061
555 FEMUR FRACTURE 188 0.0061
556 LACTIC ACIDOSIS 196 0.0060
557 GASTRIC DISORDER 207 0.0060
558 WHEEZING 357 0.0060
559 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 53 0.0060
560 TOXIC EPIDERMAL NECROLYSIS 91 0.0060
561 DYSURIA 220 0.0060
562 URINARY INCONTINENCE 177 0.0060
563 HOSPICE CARE 59 0.0060
564 COUGH 1668 0.0059
565 PERITONITIS BACTERIAL 60 0.0059
566 SMALL INTESTINAL OBSTRUCTION 73 0.0059
567 ANURIA 51 0.0059
568 HEART RATE DECREASED 208 0.0059
569 GASTROINTESTINAL HAEMORRHAGE 494 0.0059
570 RESPIRATORY FAILURE 430 0.0059
571 PULMONARY FIBROSIS 113 0.0059
572 HYPOMAGNESAEMIA 82 0.0059
573 HEART RATE INCREASED 582 0.0059
574 FACIAL PARALYSIS 50 0.0059
575 ATRIAL SEPTAL DEFECT 49 0.0058
576 RED BLOOD CELL COUNT DECREASED 167 0.0058
577 PLEURAL EFFUSION 354 0.0058
578 DYSPHAGIA 552 0.0058
579 ILEUS 72 0.0058
580 BACTERIAL INFECTION 108 0.0058
581 GASTRITIS 152 0.0058
582 PNEUMONIA BACTERIAL 53 0.0058
583 GALLBLADDER DISORDER 103 0.0058
584 NOCTURIA 70 0.0058
585 TREATMENT NONCOMPLIANCE 315 0.0058
586 HEART RATE IRREGULAR 130 0.0057
587 EAR INFECTION 153 0.0057
588 HYPOTENSION 1150 0.0057
589 ANXIETY 1631 0.0057
590 SUBDURAL HAEMATOMA 82 0.0057
591 METABOLIC ACIDOSIS 183 0.0057
592 OSTEOPOROSIS 235 0.0057
593 DIPLOPIA 148 0.0057
594 RESPIRATORY TRACT INFECTION 148 0.0057
595 CONSTIPATION 1238 0.0057
596 LETHARGY 326 0.0057
597 NEUTROPHIL COUNT INCREASED 58 0.0057
598 THYROID CANCER 68 0.0056
599 HAEMOGLOBIN DECREASED 580 0.0056
600 MOVEMENT DISORDER 181 0.0056
601 ASTHMA 637 0.0056
602 DYSPNOEA 3186 0.0056
603 TOOTH DISORDER 125 0.0056
604 INFECTION 813 0.0056
605 ACCIDENTAL OVERDOSE 205 0.0056
606 LEUKOCYTOSIS 101 0.0056
607 HYPERTENSIVE CRISIS 62 0.0056
608 DIZZINESS POSTURAL 54 0.0056
609 HERNIA 107 0.0055
610 ERECTILE DYSFUNCTION 142 0.0055
611 UPPER GASTROINTESTINAL HAEMORRHAGE 93 0.0055
612 SKIN INFECTION 62 0.0055
613 UPPER RESPIRATORY TRACT INFECTION 255 0.0055
614 HYPOAESTHESIA 824 0.0055
615 EXTRA DOSE ADMINISTERED 223 0.0055
616 RESTLESS LEGS SYNDROME 100 0.0055
617 BODY TEMPERATURE DECREASED 54 0.0055
618 SPUTUM DISCOLOURED 52 0.0055
619 FEELING HOT 336 0.0055
620 BLOOD PRESSURE DECREASED 364 0.0055
621 INTRAOCULAR PRESSURE INCREASED 70 0.0055
622 ULCER 87 0.0055
623 IMMUNE SYSTEM DISORDER 72 0.0055
624 BACK PAIN 1268 0.0055
625 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 982 0.0054
626 PALLOR 148 0.0054
627 OCULAR DISCOMFORT 61 0.0054
628 PRODUCTIVE COUGH 259 0.0054
629 VASCULITIS 63 0.0054
630 ARRHYTHMIA 255 0.0054
631 SWELLING 503 0.0054
632 OXYGEN SATURATION DECREASED 302 0.0054
633 JOINT RANGE OF MOTION DECREASED 72 0.0054
634 RHEUMATOID ARTHRITIS 609 0.0054
635 HOSPITALISATION 824 0.0054
636 ANGER 181 0.0053
637 MUSCULOSKELETAL PAIN 280 0.0053
638 BLISTER 300 0.0053
639 FLATULENCE 302 0.0053
640 DRY THROAT 54 0.0053
641 BRADYCARDIA 279 0.0053
642 INJECTION SITE URTICARIA 129 0.0053
643 PRODUCT ADMINISTRATION ERROR 106 0.0052
644 HYPOTHERMIA 53 0.0052
645 TOOTH INFECTION 69 0.0052
646 HAIR COLOUR CHANGES 65 0.0052
647 DIARRHOEA 3366 0.0052
648 BLADDER CANCER 307 0.0052
649 FEELING COLD 145 0.0052
650 HEAD DISCOMFORT 92 0.0052
651 PAIN 3188 0.0052
652 LYMPHOMA 80 0.0052
653 NASAL CONGESTION 304 0.0052
654 INJECTION SITE HAEMATOMA 75 0.0052
655 ABDOMINAL PAIN 1198 0.0051
656 TACHYPNOEA 70 0.0051
657 EYE PAIN 290 0.0051
658 CEREBRAL HAEMORRHAGE 183 0.0051
659 CHOLESTASIS 98 0.0051
660 DRY MOUTH 414 0.0051
661 LUNG INFECTION 79 0.0051
662 RHABDOMYOLYSIS 212 0.0051
663 BLOOD BILIRUBIN INCREASED 137 0.0051
664 PERITONITIS 105 0.0051
665 DEPRESSED MOOD 268 0.0051
666 POOR QUALITY SLEEP 109 0.0051
667 HAEMATOMA 131 0.0051
668 PNEUMONIA ASPIRATION 126 0.0050
669 COVID-19 883 0.0050
670 BURSITIS 61 0.0050
671 FATIGUE 3912 0.0050
672 HYPERCALCAEMIA 62 0.0050
673 VENTRICULAR EXTRASYSTOLES 52 0.0050
674 HEADACHE 3133 0.0050
675 HAEMATURIA 171 0.0050
676 HYPERSENSITIVITY 925 0.0050
677 HAEMORRHOIDS 97 0.0050
678 NEOPLASM 57 0.0050
679 HERPES ZOSTER 284 0.0049
680 MUSCLE SPASMS 904 0.0049
681 MENTAL DISORDER 214 0.0049
682 BLOOD CALCIUM DECREASED 55 0.0049
683 SPINAL PAIN 57 0.0049
684 PNEUMOTHORAX 77 0.0049
685 PARAESTHESIA ORAL 70 0.0048
686 WHITE BLOOD CELL COUNT INCREASED 186 0.0048
687 DEPRESSION 1099 0.0048
688 INFLUENZA LIKE ILLNESS 397 0.0048
689 RESPIRATORY DISTRESS 133 0.0048
690 DRUG INTERACTION 764 0.0048
691 DRUG EFFECT DECREASED 259 0.0048
692 HEPATIC FAILURE 144 0.0048
693 EAR DISCOMFORT 49 0.0048
694 TRANSFUSION 50 0.0048
695 ANHEDONIA 125 0.0048
696 DEVICE RELATED INFECTION 73 0.0047
697 HYPONATRAEMIA 267 0.0047
698 DERMATITIS CONTACT 54 0.0047
699 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 334 0.0047
700 CLOSTRIDIUM DIFFICILE INFECTION 102 0.0047
701 MUSCULOSKELETAL CHEST PAIN 72 0.0046
702 CONVULSION 266 0.0046
703 HYPOCALCAEMIA 88 0.0046
704 SOMNOLENCE 935 0.0046
705 GASTRIC ULCER 88 0.0046
706 NIGHT SWEATS 149 0.0046
707 ABDOMINAL DISCOMFORT 774 0.0046
708 CHILLS 538 0.0046
709 JAUNDICE 123 0.0046
710 MUSCLE TIGHTNESS 74 0.0046
711 BURNING SENSATION 320 0.0046
712 INJECTION SITE RASH 140 0.0046
713 MYALGIA 775 0.0046
714 INJECTION SITE IRRITATION 58 0.0046
715 URINARY RETENTION 152 0.0046
716 RESPIRATORY DISORDER 136 0.0045
717 GASTROINTESTINAL PAIN 50 0.0045
718 TENDON RUPTURE 56 0.0045
719 INJURY 318 0.0045
720 BLOOD PRESSURE FLUCTUATION 108 0.0045
721 HAEMATEMESIS 114 0.0045
722 IMMUNODEFICIENCY 67 0.0045
723 CARDIAC ARREST 371 0.0045
724 OESOPHAGITIS 49 0.0045
725 RASH PRURITIC 243 0.0045
726 TACHYCARDIA 398 0.0045
727 FREQUENT BOWEL MOVEMENTS 120 0.0044
728 SEIZURE 513 0.0044
729 SPLENOMEGALY 52 0.0044
730 SKIN DISORDER 148 0.0044
731 BRAIN OEDEMA 56 0.0044
732 GASTRIC HAEMORRHAGE 51 0.0044
733 CYST 55 0.0044
734 FAECES DISCOLOURED 96 0.0044
735 GAMMA-GLUTAMYLTRANSFERASE INCREASED 98 0.0044
736 OROPHARYNGEAL PAIN 409 0.0044
737 SURGERY 259 0.0044
738 ORAL CANDIDIASIS 58 0.0044
739 DEVICE USE ISSUE 77 0.0044
740 EYE SWELLING 163 0.0044
741 SINUS TACHYCARDIA 62 0.0044
742 NERVOUS SYSTEM DISORDER 136 0.0044
743 SKIN DISCOLOURATION 200 0.0043
744 TASTE DISORDER 88 0.0043
745 LACRIMATION INCREASED 131 0.0043
746 CARDIO-RESPIRATORY ARREST 181 0.0043
747 TENDONITIS 67 0.0043
748 CANDIDA INFECTION 73 0.0043
749 SWOLLEN TONGUE 135 0.0043
750 PROTEINURIA 82 0.0043
751 SPINAL OPERATION 53 0.0043
752 VERTIGO 262 0.0043
753 DERMATITIS ALLERGIC 54 0.0043
754 PYREXIA 1478 0.0043
755 EAR PAIN 83 0.0043
756 HAIR TEXTURE ABNORMAL 57 0.0043
757 SKIN EXFOLIATION 359 0.0043
758 INSURANCE ISSUE 65 0.0042
759 INTENTIONAL PRODUCT USE ISSUE 372 0.0042
760 PANCYTOPENIA 237 0.0042
761 NECK PAIN 237 0.0042
762 EPISTAXIS 317 0.0042
763 HEPATOCELLULAR INJURY 60 0.0042
764 CONTRAINDICATED PRODUCT ADMINISTERED 128 0.0042
765 MADAROSIS 49 0.0042
766 COAGULOPATHY 70 0.0042
767 INJECTION SITE PRURITUS 281 0.0042
768 DISTURBANCE IN ATTENTION 226 0.0042
769 SHOCK 96 0.0042
770 RASH GENERALISED 108 0.0042
771 HEPATITIS C 50 0.0041
772 UNEVALUABLE EVENT 313 0.0041
773 EYE PRURITUS 139 0.0041
774 INTESTINAL OBSTRUCTION 155 0.0041
775 BEDRIDDEN 54 0.0041
776 BLOOD CREATINE PHOSPHOKINASE INCREASED 118 0.0041
777 DEVICE ISSUE 367 0.0041
778 THERAPEUTIC RESPONSE DECREASED 248 0.0041
779 BLOOD COUNT ABNORMAL 62 0.0041
780 CYTOKINE RELEASE SYNDROME 82 0.0041
781 KNEE ARTHROPLASTY 86 0.0041
782 HYPERTHYROIDISM 59 0.0041
783 INSOMNIA 1085 0.0041
784 ALANINE AMINOTRANSFERASE INCREASED 250 0.0041
785 BODY TEMPERATURE INCREASED 83 0.0041
786 SUICIDE ATTEMPT 246 0.0041
787 PROCEDURAL PAIN 112 0.0040
788 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 188 0.0040
789 DYSGEUSIA 299 0.0040
790 BRAIN FOG 63 0.0040
791 CRYING 145 0.0040
792 RECTAL HAEMORRHAGE 171 0.0040
793 HAEMATOCHEZIA 218 0.0039
794 VENTRICULAR TACHYCARDIA 65 0.0039
795 ASPARTATE AMINOTRANSFERASE INCREASED 209 0.0039
796 MULTIPLE ORGAN DYSFUNCTION SYNDROME 111 0.0039
797 BLOOD TEST ABNORMAL 55 0.0039
798 GINGIVAL BLEEDING 53 0.0039
799 FULL BLOOD COUNT DECREASED 78 0.0039
800 DEVICE DEFECTIVE 67 0.0039
801 SKIN LESION 106 0.0039
802 IRRITABILITY 231 0.0038
803 COGNITIVE DISORDER 179 0.0038
804 SLEEP DISORDER 269 0.0038
805 CHROMATURIA 86 0.0038
806 ACCIDENTAL EXPOSURE TO PRODUCT 392 0.0038
807 NEEDLE ISSUE 110 0.0038
808 EOSINOPHILIA 66 0.0038
809 PANIC ATTACK 137 0.0038
810 INFLAMMATION 194 0.0038
811 URTICARIA 629 0.0038
812 DRY EYE 187 0.0037
813 PAIN IN JAW 106 0.0037
814 LIVER FUNCTION TEST INCREASED 80 0.0037
815 JOINT SWELLING 447 0.0037
816 TOOTHACHE 67 0.0037
817 MIDDLE INSOMNIA 69 0.0037
818 OSTEOPENIA 56 0.0037
819 RASH MACULO-PAPULAR 82 0.0037
820 DEVICE MALFUNCTION 259 0.0037
821 PRODUCT USE ISSUE 692 0.0037
822 EJECTION FRACTION DECREASED 57 0.0037
823 BASAL CELL CARCINOMA 57 0.0036
824 FRACTURE 69 0.0036
825 MULTI-ORGAN FAILURE 63 0.0036
826 ABORTION SPONTANEOUS 146 0.0036
827 IRRITABLE BOWEL SYNDROME 78 0.0036
828 EMOTIONAL DISORDER 112 0.0036
829 PRODUCT QUALITY ISSUE 492 0.0036
830 PLATELET COUNT DECREASED 386 0.0036
831 PULMONARY EMBOLISM 344 0.0036
832 ARTHRALGIA 1499 0.0036
833 HALLUCINATION, VISUAL 76 0.0036
834 HEPATITIS 92 0.0036
835 MOOD ALTERED 98 0.0036
836 PULMONARY ARTERIAL HYPERTENSION 52 0.0036
837 PRURITUS 1379 0.0036
838 PLASMA CELL MYELOMA 140 0.0036
839 ABNORMAL BEHAVIOUR 142 0.0036
840 ORAL PAIN 80 0.0036
841 STEVENS-JOHNSON SYNDROME 79 0.0035
842 MULTIPLE FRACTURES 58 0.0035
843 METASTASES TO LIVER 62 0.0035
844 THROMBOCYTOPENIA 393 0.0035
845 THROAT IRRITATION 157 0.0035
846 SENSORY DISTURBANCE 56 0.0035
847 DELIRIUM 121 0.0035
848 HEPATIC FUNCTION ABNORMAL 130 0.0035
849 COLITIS 132 0.0035
850 AGITATION 255 0.0035
851 C-REACTIVE PROTEIN INCREASED 126 0.0035
852 CONDITION AGGRAVATED 1051 0.0035
853 EYE IRRITATION 198 0.0034
854 FACE OEDEMA 58 0.0034
855 PSORIASIS 449 0.0034
856 MUSCULOSKELETAL STIFFNESS 301 0.0034
857 CHOKING 67 0.0034
858 TINNITUS 157 0.0034
859 RESPIRATORY ARREST 94 0.0034
860 FEBRILE NEUTROPENIA 226 0.0034
861 THROAT TIGHTNESS 92 0.0034
862 SWELLING FACE 221 0.0034
863 LIP SWELLING 113 0.0034
864 DEEP VEIN THROMBOSIS 220 0.0034
865 PSYCHOMOTOR HYPERACTIVITY 56 0.0034
866 PARAESTHESIA 529 0.0034
867 JOINT STIFFNESS 88 0.0034
868 PHOTOPHOBIA 63 0.0033
869 CIRCULATORY COLLAPSE 57 0.0033
870 AGRANULOCYTOSIS 62 0.0033
871 LUNG NEOPLASM MALIGNANT 137 0.0033
872 LOCAL SWELLING 58 0.0033
873 BLOOD URINE PRESENT 63 0.0033
874 PNEUMONITIS 90 0.0033
875 PREGNANCY 66 0.0033
876 BREAST CANCER 306 0.0033
877 TRANSAMINASES INCREASED 73 0.0033
878 SYNOVITIS 59 0.0033
879 SKIN CANCER 70 0.0032
880 CONJUNCTIVITIS 60 0.0032
881 ACTIVITIES OF DAILY LIVING IMPAIRED 64 0.0032
882 DRUG-INDUCED LIVER INJURY 101 0.0032
883 LYMPHOCYTE COUNT DECREASED 56 0.0032
884 INTENTIONAL OVERDOSE 203 0.0032
885 DRUG ERUPTION 56 0.0032
886 ECZEMA 163 0.0031
887 THERAPY NON-RESPONDER 140 0.0031
888 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 149 0.0031
889 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 219 0.0031
890 THERAPEUTIC RESPONSE UNEXPECTED 138 0.0031
891 LIVER FUNCTION TEST ABNORMAL 89 0.0031
892 DYSKINESIA 124 0.0030
893 MIGRAINE 291 0.0030
894 PSORIATIC ARTHROPATHY 122 0.0030
895 ACUTE RESPIRATORY DISTRESS SYNDROME 53 0.0030
896 MUSCLE TWITCHING 69 0.0030
897 INJECTION SITE SWELLING 228 0.0030
898 BONE PAIN 174 0.0030
899 DERMATITIS 62 0.0030
900 LABORATORY TEST ABNORMAL 87 0.0029
901 EPILEPSY 90 0.0029
902 DEVICE LEAKAGE 127 0.0029
903 HALLUCINATION 219 0.0029
904 ELECTROCARDIOGRAM QT PROLONGED 104 0.0029
905 AGEUSIA 72 0.0029
906 INJECTION SITE ERYTHEMA 358 0.0029
907 LYMPHADENOPATHY 102 0.0029
908 INTENTIONAL DOSE OMISSION 82 0.0029
909 ERYTHEMA 591 0.0029
910 INJECTION SITE REACTION 197 0.0029
911 DEATH 2453 0.0028
912 RASH 1241 0.0028
913 HEPATIC ENZYME INCREASED 194 0.0028
914 RASH MACULAR 99 0.0028
915 OFF LABEL USE 2468 0.0028
916 INTERSTITIAL LUNG DISEASE 136 0.0028
917 TOOTH LOSS 58 0.0028
918 THERAPY CESSATION 142 0.0028
919 RESTLESSNESS 101 0.0028
920 HOT FLUSH 204 0.0027
921 STOMATITIS 164 0.0027
922 WHITE BLOOD CELL COUNT DECREASED 291 0.0027
923 MULTIPLE SCLEROSIS 127 0.0027
924 DRUG EFFECT INCOMPLETE 96 0.0026
925 INFUSION RELATED REACTION 175 0.0026
926 ANAPHYLACTIC SHOCK 68 0.0026
927 RASH PAPULAR 59 0.0026
928 ANAPHYLACTIC REACTION 145 0.0026
929 AGGRESSION 130 0.0026
930 LOWER RESPIRATORY TRACT INFECTION 118 0.0026
931 ALOPECIA 508 0.0026
932 FLUSHING 261 0.0026
933 SYSTEMIC LUPUS ERYTHEMATOSUS 91 0.0026
934 OCULAR HYPERAEMIA 121 0.0025
935 ANGIOEDEMA 112 0.0025
936 RASH ERYTHEMATOUS 121 0.0025
937 NEUTROPENIA 342 0.0025
938 PRESCRIBED UNDERDOSE 50 0.0025
939 DRUG INTOLERANCE 242 0.0025
940 LIVER INJURY 61 0.0025
941 INTENTIONAL DRUG MISUSE 50 0.0024
942 EMOTIONAL DISTRESS 284 0.0023
943 LEUKOPENIA 117 0.0023
944 DRUG RESISTANCE 60 0.0023
945 MUCOSAL INFLAMMATION 61 0.0023
946 ABNORMAL DREAMS 64 0.0023
947 IMPAIRED WORK ABILITY 49 0.0023
948 NIGHTMARE 79 0.0023
949 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 77 0.0023
950 EXPOSURE VIA SKIN CONTACT 59 0.0023
951 ABDOMINAL PAIN LOWER 57 0.0023
952 ILL-DEFINED DISORDER 133 0.0022
953 INCORRECT ROUTE OF DRUG ADMINISTRATION 78 0.0022
954 THERAPY INTERRUPTED 155 0.0022
955 VAGINAL HAEMORRHAGE 93 0.0021
956 PRODUCT SUBSTITUTION ISSUE 123 0.0021
957 DRY SKIN 284 0.0021
958 MOOD SWINGS 67 0.0021
959 SUICIDAL IDEATION 187 0.0020
960 ADVERSE DRUG REACTION 183 0.0020
961 NEOPLASM PROGRESSION 70 0.0020
962 DEVICE DELIVERY SYSTEM ISSUE 55 0.0020
963 ADVERSE EVENT 185 0.0020
964 PRODUCT DOSE OMISSION IN ERROR 56 0.0020
965 NEUTROPHIL COUNT DECREASED 79 0.0019
966 COLITIS ULCERATIVE 86 0.0019
967 DISEASE PROGRESSION 223 0.0019
968 TARDIVE DYSKINESIA 53 0.0019
969 OVERDOSE 403 0.0019
970 MALIGNANT NEOPLASM PROGRESSION 187 0.0018
971 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 97 0.0018
972 THERAPEUTIC PRODUCT EFFECT DECREASED 79 0.0018
973 RENAL CANCER 83 0.0017
974 PRODUCT USE IN UNAPPROVED INDICATION 429 0.0017
975 ACNE 131 0.0017
976 THERAPEUTIC RESPONSE SHORTENED 56 0.0017
977 PSYCHOTIC DISORDER 49 0.0017
978 DEVICE BREAKAGE 66 0.0016
979 DISEASE RECURRENCE 76 0.0016
980 PROSTATE CANCER 126 0.0016
981 SKIN IRRITATION 65 0.0014
982 WITHDRAWAL SYNDROME 58 0.0014
983 COMPLETED SUICIDE 113 0.0014
984 SKIN BURNING SENSATION 92 0.0013
985 NO ADVERSE EVENT 227 0.0013
986 TOXICITY TO VARIOUS AGENTS 198 0.0012
987 DRUG ABUSE 97 0.0012
988 TREATMENT FAILURE 94 0.0011
989 MULTIPLE SCLEROSIS RELAPSE 73 0.0011
990 DRUG WITHDRAWAL SYNDROME 71 0.0008
991 DRUG DOSE OMISSION BY DEVICE 62 0.0008
992 DRUG DEPENDENCE 53 0.0003